Orbimed Advisors - GRAPHITE BIO INC ownership

GRAPHITE BIO INC's ticker is GRPH and the CUSIP is 38870X104. A total of 60 filers reported holding GRAPHITE BIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of GRAPHITE BIO INC
ValueSharesWeighting
Q3 2022$2,689,000
+15.3%
848,4120.0%0.05%
+19.0%
Q2 2022$2,333,000
-70.8%
848,412
-45.8%
0.04%
-67.4%
Q1 2022$7,986,000
-59.0%
1,565,8120.0%0.13%
-48.4%
Q4 2021$19,463,000
-18.1%
1,565,812
+8.0%
0.25%
-4.2%
Q3 2021$23,764,000
-30.1%
1,449,904
+31.1%
0.26%
-24.1%
Q2 2021$33,997,0001,106,3070.34%
Other shareholders
GRAPHITE BIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 8,459,314$20,979,0996.42%
OUP Management Co., LLC 406,308$1,007,6442.27%
Prosight Management, LP 1,337,826$3,317,8081.05%
EcoR1 Capital, LLC 8,538,446$21,175,3460.71%
TANG CAPITAL MANAGEMENT LLC 2,016,626$5,001,2320.71%
Privium Fund Management (UK) Ltd 191,244$453,2480.36%
Newtyn Management, LLC 542,637$1,345,7400.33%
Aldebaran Capital, LLC 130,000$322,4000.33%
Acuitas Investments, LLC 195,762$485,4900.28%
CHI Advisors LLC 230,938$572,7260.23%
View complete list of GRAPHITE BIO INC shareholders